1. Home
  2. SYPR vs CGTX Comparison

SYPR vs CGTX Comparison

Compare SYPR & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYPR
  • CGTX
  • Stock Information
  • Founded
  • SYPR 1997
  • CGTX 2007
  • Country
  • SYPR United States
  • CGTX United States
  • Employees
  • SYPR N/A
  • CGTX N/A
  • Industry
  • SYPR Industrial Machinery/Components
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYPR Industrials
  • CGTX Health Care
  • Exchange
  • SYPR Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • SYPR 48.7M
  • CGTX 53.4M
  • IPO Year
  • SYPR 1994
  • CGTX 2021
  • Fundamental
  • Price
  • SYPR $2.05
  • CGTX $0.84
  • Analyst Decision
  • SYPR
  • CGTX Strong Buy
  • Analyst Count
  • SYPR 0
  • CGTX 4
  • Target Price
  • SYPR N/A
  • CGTX $2.83
  • AVG Volume (30 Days)
  • SYPR 34.8K
  • CGTX 19.4M
  • Earning Date
  • SYPR 08-12-2025
  • CGTX 08-07-2025
  • Dividend Yield
  • SYPR N/A
  • CGTX N/A
  • EPS Growth
  • SYPR N/A
  • CGTX N/A
  • EPS
  • SYPR N/A
  • CGTX N/A
  • Revenue
  • SYPR $134,135,000.00
  • CGTX N/A
  • Revenue This Year
  • SYPR N/A
  • CGTX N/A
  • Revenue Next Year
  • SYPR N/A
  • CGTX N/A
  • P/E Ratio
  • SYPR N/A
  • CGTX N/A
  • Revenue Growth
  • SYPR N/A
  • CGTX N/A
  • 52 Week Low
  • SYPR $1.30
  • CGTX $0.22
  • 52 Week High
  • SYPR $3.72
  • CGTX $2.54
  • Technical
  • Relative Strength Index (RSI)
  • SYPR 50.13
  • CGTX 72.32
  • Support Level
  • SYPR $1.99
  • CGTX $0.55
  • Resistance Level
  • SYPR $2.12
  • CGTX $0.87
  • Average True Range (ATR)
  • SYPR 0.11
  • CGTX 0.10
  • MACD
  • SYPR -0.01
  • CGTX 0.02
  • Stochastic Oscillator
  • SYPR 19.64
  • CGTX 61.76

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: